HealthcareServices

Precision Psychiatry Global Forecast: Market to Scale Up to $9.8 Billion by 2030 at 14.4% CAGR

March 2, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the precision psychiatry market from 2026–2035 with trusted insights from The Business Research Company

What was the valuation of the Precision Psychiatry Market in 2026, and what figure is it projected to hit by 2030?

The precision psychiatry market has shown substantial growth in recent years. It is anticipated to expand from $4.99 billion in 2025 to $5.72 billion in 2026, registering a compound annual growth rate (CAGR) of 14.7%. The market’s historical advancement is linked to the escalating prevalence of mental health conditions, the expanding constraints of trial-and-error prescribing methods, the broadening scope of psychiatric research initiatives, the increasing access to neuroimaging technologies, and the early incorporation of pharmacogenomics in psychiatry.

The precision psychiatry market is poised for significant expansion in the coming years. Its valuation is projected to reach $9.81 billion by 2030, exhibiting a robust compound annual growth rate (CAGR) of 14.4%. This anticipated growth throughout the forecast period can be ascribed to various factors, including an increase in investments toward precision medicine platforms, the growing adoption of AI-enabled diagnostics, the expansion of digital mental health solutions, a rising need for personalized psychiatric care, and a heightened focus on preventive mental health strategies. Concurrently, major trends expected during this period encompass the increasing uptake of biomarker-guided treatment pathways, the rising utilization of digital phenotyping tools, the expanding integration of genetic and neuroimaging data, the broader application of AI-driven clinical decision support, and an enhanced emphasis on personalized mental health monitoring.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=30359&type=smp

Which Drivers Are Affecting Market Participation In The Precision Psychiatry Market?

The rising incidence of mental health conditions is anticipated to fuel the expansion of the precision psychiatry market moving forward. These conditions encompass various issues like depression, anxiety, and bipolar disorder, impacting an individual’s mood, thought processes, and behavior. The increase in mental health disorders is attributed to a greater number of people facing psychological challenges due to societal, economic, and environmental factors, alongside enhanced screening methods and increased public knowledge leading to higher rates of diagnosis. Precision psychiatry tackles mental health issues through the implementation of data-informed, tailored treatment approaches, thereby enhancing diagnostic precision and therapeutic results. A notable illustration of this trend is found in November 2023, where NHS England, the UK-based publicly funded national health authority, reported an increase in the probable mental disorder rate for individuals aged 20 to 23 years, climbing from 18.7% in 2022 to 21.6% in 2023. Consequently, the growing occurrence of mental health disorders is propelling the development of the precision psychiatry market.

What Segment Categories Are Covered In The Precision Psychiatry Market?

The precision psychiatry market covered in this report is segmented –

1) By Therapeutic Approaches: Pharmacotherapy, Psychotherapy, Neurostimulation, Digital Therapeutics, Combination Therapies

2) By Technology: Genetic Testing, Biomarker Analysis, Brain Imaging Techniques, Wearable Devices, Artificial Intelligence And Machine Learning Solutions

3) By Disorders: Depression, Anxiety Disorders, Bipolar Disorder, Schizophrenia, Post-Traumatic Stress Disorder (PTSD)

4) By Application: Diagnosis, Treatment, Research

5) By End User: Clinics, Hospitals, Research Institutes, Pharmaceutical Companies, Home Care Settings

Subsegments:

1) By Pharmacotherapy: Antidepressant Medications, Antipsychotic Medications, Mood Stabilizers, Anxiolytic Medications, Stimulant Medications

2) By Psychotherapy: Cognitive Behavioral Therapy, Interpersonal Therapy, Psychodynamic Therapy, Dialectical Behavior Therapy, Mindfulness-Based Therapy

3) By Neurostimulation: Transcranial Magnetic Stimulation, Electroconvulsive Therapy, Vagus Nerve Stimulation, Deep Brain Stimulation, Transcranial Direct Current Stimulation

4) By Digital Therapeutics: Mobile Application-Based Therapy, Virtual Reality Therapy, Web-Based Cognitive Behavioral Programs, Remote Patient Monitoring Tools, Artificial Intelligence-Guided Interventions

5) By Combination Therapies: Pharmacotherapy And Psychotherapy Combination, Pharmacotherapy And Neurostimulation Combination, Pharmacotherapy And Digital Therapeutics Combination, Psychotherapy And Neurostimulation Combination, Multimodal Precision Treatment Programs

What Industry Trends Are Transforming The Precision Psychiatry Market?

Leading companies in the precision psychiatry market are concentrating on creating novel therapies, such as prescription digital therapeutics, to enable tailored and data-driven interventions for psychiatric conditions. A prescription digital therapeutic serves as a clinician-prescribed, software-based medical intervention that provides evidence-based behavioral therapy modules through mobile devices to enhance symptom improvement and treatment adherence. For example, in August 2024, Otsuka Precision Health Inc., a US-based precision health subsidiary of Otsuka Holdings, collaborated with Click Therapeutics Inc., a US-based digital therapeutics company, to introduce Rejoyn. This product represents the first and sole prescription digital therapeutic approved by the United States Food and Drug Administration (FDA) for the adjunctive management of major depressive disorder (MDD) symptoms. Rejoyn offers a six-week cognitive-emotional training program that integrates the emotional faces memory task with cognitive behavioral therapy (CBT)–based skill modules, facilitating digital prescribing, patient engagement, and remote monitoring. The introduction of Rejoyn marks a pivotal moment in Precision Psychiatry, illustrating how digital therapeutics can supplement pharmacological treatments to deliver individualized care. Furthermore, it prepares the ground for broader acceptance of software-based interventions that integrate real-time patient data to refine treatment outcomes and adherence.

Which Key Players Are Driving Competition In The Precision Psychiatry Market?

Major companies operating in the precision psychiatry market are Johnson & Johnson, F. Hoffmann-La Roche Ltd, Pfizer Inc., AbbVie Inc., AstraZeneca plc, Novartis AG, Bristol-Myers Squibb Company, Eli Lilly and Company, Otsuka Pharmaceutical Company Limited, Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Illumina Inc., ARUP Laboratories Inc., Sumitomo Dainippon Pharma Company Limited, QIAGEN N.V., Neurocrine Biosciences Inc., Tempus Labs Inc., Myriad Genetics Inc., MedGenome Labs Ltd., Genomind Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/global-precision-psychiatry-market-report

Which Region Is Projected To Lead The Precision Psychiatry Market During The Forecast Period?

North America was the largest region in the precision psychiatry market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the precision psychiatry market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Precision Psychiatry Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=30359&type=smp

Browse Through More Reports Similar to the Global Precision Psychiatry Market 2026, By The Business Research Company

Digital Psychotherapeutics Market Report 2026

https://www.thebusinessresearchcompany.com/report/digital-psychotherapeutics-global-market-report

Psychiatrists Market 2026

https://www.thebusinessresearchcompany.com/report/psychiatrists-market

Precision Diagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/precision-diagnostics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795